COV
CLEO DIAGN FPO [COV]
Healthcare · ASX Small Cap
$0.5550 -5.1%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -5First seen: 2026-02-25
Score Breakdown
Technical46
Catalyst47
Sentiment50
Fundamental58
Momentum76
Risk Gate43
Active Signals
Bullish Signals
- RSI approaching oversold
- Bollinger squeeze (breakout building)
- Near support level (potential bounce)
- Sharp 5-day decline (-10.5%)
- Above 200-day MA (long-term uptrend)
- Strong cash runway (15 quarters)
- 4C filed 2026-01-28
- Strong revenue growth (+373%)
- Small-cap ($20-100M)
- Substantial holder(s) ceased (1)
- Strong 12-1 momentum (+70%)
- Strong revenue momentum (+373%)
- Altman Z-Score in grey zone (1.87)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Deeply negative margins (-164%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Appendix 4D and Half Yearly Accounts
NONE CLEO Confirms Next-Gen Platform for Ovarian Cancer Test
NONE Quarterly activities and cashflow report
HIGH Ceasing to be a substantial holder
Announcement tone -3pts
Recent ASX Announcements
| 2026-02-25 | Appendix 4D and Half Yearly Accounts PRICE SENSITIVE |
| 2026-02-17 | CLEO Confirms Next-Gen Platform for Ovarian Cancer Test PRICE SENSITIVE |
| 2026-01-28 | Quarterly activities and cashflow report PRICE SENSITIVE |
| 2026-01-05 | Ceasing to be a substantial holder |
Key Metrics
$80.1M
Market Cap
309K
Avg Volume
0.7x
Vol Ratio
$0.31 — $0.90
52-Week Range
N/A
Short Interest
15 qtrs
Cash Runway
-49.6%
ROE
-163.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 56% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #76 of 119 · Sector avg: 51
View all Healthcare signals →